Indiana University Melvin and Bren Simon Cancer Center ( Site 3071) is a clinical research site located in Indianapolis, Indiana, United States 46202.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Indiana University Melvin and Bren Simon Cancer Center ( Site 3071) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Endometrial Neoplasms.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Indiana University Melvin and Bren Simon Cancer Center ( Site 3071) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Indiana University Melvin and Bren Simon Cancer Center ( Site 3071) has 1 clinical trials on record, with 1 currently active. Their work covers Endometrial Neoplasms.
Indiana University Melvin and Bren Simon Cancer Center ( Site 3071) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.